The company has several juicy growth opportunities ahead of it, a market professional tracking its fortunes believes.

Vertex has the revenue power to excel during any market environment.

Though it still has strong prospects, this goal seems far too difficult to achieve.

Vertex Pharmaceuticals stock: context for recent performance Vertex Pharmaceuticals (VRTX) has attracted attention recently as investors weigh its current share price of $496.83 against company ...

Live webcasts and replays of both presentations will be available on Vertex’s investor relations website at ir.vertex.com.

Financial giants have made a conspicuous bullish move on Vertex Pharmaceuticals. Our analysis of options history for Vertex Pharmaceuticals (NASDAQ:VRTX) revealed 35 unusual trades. Delving into the ...